MX2015011783A - Metodos para tratar tumores solidos pediatricos. - Google Patents
Metodos para tratar tumores solidos pediatricos.Info
- Publication number
- MX2015011783A MX2015011783A MX2015011783A MX2015011783A MX2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A MX 2015011783 A MX2015011783 A MX 2015011783A
- Authority
- MX
- Mexico
- Prior art keywords
- solid tumor
- methods
- treatment
- pediatric solid
- pediatric
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 229940123237 Taxane Drugs 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780658P | 2013-03-13 | 2013-03-13 | |
| US201361805817P | 2013-03-27 | 2013-03-27 | |
| US201361829940P | 2013-05-31 | 2013-05-31 | |
| US201361909868P | 2013-11-27 | 2013-11-27 | |
| PCT/US2014/022541 WO2014143613A1 (en) | 2013-03-13 | 2014-03-10 | Methods of treatment of pediatric solid tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015011783A true MX2015011783A (es) | 2015-12-01 |
Family
ID=51537501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015011783A MX2015011783A (es) | 2013-03-13 | 2014-03-10 | Metodos para tratar tumores solidos pediatricos. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160015817A1 (enExample) |
| EP (1) | EP2968253A4 (enExample) |
| JP (3) | JP6387389B2 (enExample) |
| KR (1) | KR20150126671A (enExample) |
| CN (1) | CN105209035A (enExample) |
| AU (2) | AU2014228386B2 (enExample) |
| CA (1) | CA2903470A1 (enExample) |
| HK (1) | HK1219231A1 (enExample) |
| IL (1) | IL240987A0 (enExample) |
| MX (1) | MX2015011783A (enExample) |
| NZ (1) | NZ630367A (enExample) |
| WO (1) | WO2014143613A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US9675578B2 (en) | 2006-12-14 | 2017-06-13 | Abraxis Bioscience, Llc | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| HRP20192259T1 (hr) | 2009-04-15 | 2020-03-06 | Abraxis Bioscience, Llc | Pripravci nanočestica bez priona i metode njihove proizvodnje |
| KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| US9393318B2 (en) | 2010-03-29 | 2016-07-19 | Abraxis Bioscience, Llc | Methods of treating cancer |
| KR20130088116A (ko) | 2010-06-04 | 2013-08-07 | 아브락시스 바이오사이언스, 엘엘씨 | 췌장암의 치료 방법 |
| AU2012249371B2 (en) | 2011-04-28 | 2017-06-08 | Abraxis Bioscience, Llc | Intravascular delivery of nanoparticle compositions and uses thereof |
| PL2790675T3 (pl) | 2011-12-14 | 2019-12-31 | Abraxis Bioscience, Llc | Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| JP6349381B2 (ja) | 2013-03-12 | 2018-06-27 | アブラクシス バイオサイエンス， エルエルシー | 肺がんを処置する方法 |
| JP6309610B2 (ja) | 2013-03-14 | 2018-04-11 | アブラクシス バイオサイエンス， エルエルシー | 膀胱がんを処置する方法 |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| SMT202100642T1 (it) | 2015-06-29 | 2022-03-21 | Abraxis Bioscience Llc | Nanoparticelle comprendenti sirolimus e un'albumina per l'uso nel trattamento di tumori a cellule epitelioidi |
| AU2019239953B2 (en) | 2018-03-20 | 2025-01-02 | Abraxis Bioscience, Llc | Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin |
| IL292439B2 (en) | 2019-10-28 | 2026-05-01 | Abraxis Bioscience Llc | Pharmaceutical preparations of albumin and rapamycin |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| CN1101700C (zh) * | 1997-12-05 | 2003-02-19 | 上海众联生化技术开发有限公司 | 多肽口服液 |
| ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
| DK1585548T3 (en) | 2002-12-09 | 2018-09-03 | Abraxis Bioscience Llc | COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS |
| CN1261161C (zh) * | 2003-11-10 | 2006-06-28 | 钱汶光 | 复方干扰素诱生剂口含片 |
| CN103169729A (zh) | 2005-02-18 | 2013-06-26 | 阿布拉科斯生物科学有限公司 | 治疗剂的组合和给予方式以及联合治疗 |
| CN101291658B (zh) | 2005-08-31 | 2014-04-16 | 阿布拉科斯生物科学有限公司 | 用于制备稳定性增加的水难溶性药物的组合物和方法 |
| WO2008137148A2 (en) | 2007-05-03 | 2008-11-13 | Abraxis Bioscience, Llc | Methods and compositions for treating pulmonary hypertension |
| EP2502078A1 (en) * | 2009-11-20 | 2012-09-26 | Infinity Pharmaceuticals, Inc. | Methods and compositions for treating hedgehog-associated cancers |
| KR20130028727A (ko) * | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| CN103221042B (zh) * | 2010-06-02 | 2016-02-10 | 阿布拉科斯生物科学有限公司 | 治疗膀胱癌的方法 |
-
2014
- 2014-03-10 CN CN201480026752.3A patent/CN105209035A/zh active Pending
- 2014-03-10 US US14/771,783 patent/US20160015817A1/en not_active Abandoned
- 2014-03-10 AU AU2014228386A patent/AU2014228386B2/en not_active Ceased
- 2014-03-10 HK HK16107309.3A patent/HK1219231A1/zh unknown
- 2014-03-10 NZ NZ630367A patent/NZ630367A/en unknown
- 2014-03-10 JP JP2016500995A patent/JP6387389B2/ja active Active
- 2014-03-10 WO PCT/US2014/022541 patent/WO2014143613A1/en not_active Ceased
- 2014-03-10 CA CA2903470A patent/CA2903470A1/en not_active Abandoned
- 2014-03-10 MX MX2015011783A patent/MX2015011783A/es unknown
- 2014-03-10 EP EP14763546.0A patent/EP2968253A4/en not_active Withdrawn
- 2014-03-10 KR KR1020157027992A patent/KR20150126671A/ko not_active Ceased
-
2015
- 2015-09-01 IL IL240987A patent/IL240987A0/en unknown
-
2018
- 2018-01-24 JP JP2018009402A patent/JP2018062528A/ja not_active Withdrawn
-
2019
- 2019-02-27 AU AU2019201357A patent/AU2019201357A1/en not_active Abandoned
- 2019-07-03 JP JP2019124315A patent/JP2019163334A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019163334A (ja) | 2019-09-26 |
| AU2019201357A1 (en) | 2019-03-21 |
| EP2968253A1 (en) | 2016-01-20 |
| JP2016512513A (ja) | 2016-04-28 |
| IL240987A0 (en) | 2015-11-30 |
| EP2968253A4 (en) | 2016-11-02 |
| CA2903470A1 (en) | 2014-09-18 |
| NZ630367A (en) | 2017-02-24 |
| US20160015817A1 (en) | 2016-01-21 |
| HK1219231A1 (zh) | 2017-03-31 |
| AU2014228386A1 (en) | 2015-09-24 |
| JP2018062528A (ja) | 2018-04-19 |
| AU2014228386B2 (en) | 2018-11-29 |
| KR20150126671A (ko) | 2015-11-12 |
| CN105209035A (zh) | 2015-12-30 |
| JP6387389B2 (ja) | 2018-09-05 |
| WO2014143613A1 (en) | 2014-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219231A1 (zh) | 治疗儿童实体瘤的方法 | |
| MX378934B (es) | Composición de nanopartículas para usarse en el tratamiento de cáncer de vejiga | |
| PH12016502066A1 (en) | Methods of treating bladder cancer | |
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| MX377729B (es) | Métodos para tratamiento del melanoma. | |
| MX2015008889A (es) | Metodo para tratar cancer con base en el estado de la mutacion k-ras. | |
| IL239981A0 (en) | Combined therapy involving antibodies against claudin 18.2 for the treatment of cancer | |
| PH12015502161A1 (en) | Therapeutic compounds and compositions | |
| MX2016007885A (es) | Metodos de tratamiento de cancer usando antagonistas de union del eje de pd-1 y un anticuerpo anti-cd20. | |
| EA201992251A1 (ru) | Противораковые вакцины и способы лечения с их применением | |
| MX2020009223A (es) | Anticuerpos anti-fgfr2iiib afucosilados. | |
| MX2021002455A (es) | Metodos para tratar tumores de celulas epitelioides. | |
| NZ719049A (en) | Cancer treatment with combination of plinabulin and taxane | |
| EA201591925A1 (ru) | Терапевтические композиции и их применение | |
| MX368903B (es) | Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas. | |
| MX379271B (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cáncer. | |
| SMT202200458T1 (it) | Terapia combinata con anticorpi contro la claudina 18.2 per il trattamento del cancro | |
| EA201690445A1 (ru) | Лечение рака | |
| EA201590615A1 (ru) | Стимулирующие лактацию композиции на основе фосфатидилсерина | |
| MX2017014463A (es) | Cabazitaxel y su uso para tratar cancer. | |
| NZ725354A (en) | Transdermal formulations of pergolide and uses thereof | |
| BR112016005917A2 (pt) | conjugados de partículas semelhantes a vírus para diagnóstico e tratamento de tumores | |
| GB2546703A (en) | Compounds | |
| EA201691907A1 (ru) | Комбинированная терапия кураксинами |